Vasoya Jaydip M, Shah Ankita V, Serajuddin Abu T M
Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, 8000 Utopia Parkway, Queens, NY 11439, USA (Jaydip M. Vasoya:
Current address: Freund-Vector Corporation, 675 44th street, Marion, IA 52302, USA (Ankita V Shah:
ADMET DMPK. 2019 Apr 5;7(2):106-130. doi: 10.5599/admet.661. eCollection 2019.
Since there are conflicting reports in the literature on solubility and dissolution advantages of cocrystals over free forms, we systematically studied solubility and intrinsic dissolution rates of a weakly basic drug, ketoconazole, and its cocrystals with fumaric acid and succinic acid as functions of pH to determine what advantages cocrystals provide. pH-solubility profiles were determined in two different ways: one by lowering pH of ketoconazole aqueous suspensions using HCl, fumaric acid and succinic acid, and the other by adjusting pH of cocrystal suspensions using respective coformer acids or NaOH. Similar pH-solubility profiles were obtained whether free base or cocrystals were used as starting materials to determine solubility. With the addition of fumaric and succinic acids to aqueous suspensions of free base to lower pH, the maximum solubility (pH) was reached at pH ~3.5-4.0, below which the solubility decreased and cocrystals formed. The solubility, however, continued increasing when HCl was added to ketoconazole suspension as no cocrystal or salt was formed. During determination of cocrystal solubility, a conversion to free base was observed when pH was raised above pH. Thus, pH-solubility profiles of cocrystals resembled solubility profiles commonly encountered with salts. Above pH, both free base and cocrystal had similar solubility under identical pH conditions; the solubility of cocrystal was higher only if the pH differed. In contrast, intrinsic dissolution rates of cocrystals at pH>pH under identical bulk pH were much higher than that of free ketoconazole since cocrystals had lower microenvironmental pH at the dissolving surface, where the solubility was high. Thus, cocrystals of basic drugs can potentially provide higher dissolution rates under intestinal pH conditions.
由于文献中关于共晶在溶解性和溶出优势方面相对于游离形式存在相互矛盾的报道,我们系统地研究了一种弱碱性药物酮康唑及其与富马酸和琥珀酸形成的共晶的溶解度和固有溶出速率与pH的关系,以确定共晶具有哪些优势。通过两种不同方法测定了pH-溶解度曲线:一种是使用HCl、富马酸和琥珀酸降低酮康唑水悬浮液的pH,另一种是使用各自的共形成酸或NaOH调节共晶悬浮液的pH。无论使用游离碱还是共晶作为起始原料来测定溶解度,都获得了相似的pH-溶解度曲线。向游离碱的水悬浮液中添加富马酸和琥珀酸以降低pH时,在pH约3.5 - 4.0时达到最大溶解度(pH),低于此pH溶解度降低并形成共晶。然而,当向酮康唑悬浮液中添加HCl时,由于未形成共晶或盐,溶解度持续增加。在测定共晶溶解度时,当pH升高到pH以上时观察到向游离碱的转化。因此,共晶的pH-溶解度曲线类似于盐常见的溶解度曲线。在pH以上,游离碱和共晶在相同pH条件下具有相似的溶解度;只有当pH不同时,共晶的溶解度才更高。相比之下,在相同的总体pH下,pH>pH时共晶的固有溶出速率比游离酮康唑高得多,因为共晶在溶解表面的微环境pH较低,而此处溶解度较高。因此,碱性药物的共晶在肠道pH条件下可能具有更高的溶出速率。